This study tests an experimental drug called RP1 that is injected directly into skin cancer tumors. The goal is to see if it can shrink or eliminate the cancer before surgery. About 12 adults with resectable cutaneous squamous cell carcinoma will participate. The main focus is sa…
Phase: PHASE1, PHASE2 • Sponsor: Sherrif Ibrahim • Aim: Disease control
Last updated May 17, 2026 10:05 UTC